CeriBell

CeriBell

Yahoo Finance • 3 days ago

Ceribell to Participate in the Canaccord Genuity 46th Annual Growth Conference

SUNNYVALE, Calif., July 28, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today an... Full story

Yahoo Finance • 11 days ago

Ceribell to Report Second Quarter 2026 Financial Results on August 10, 2026

SUNNYVALE, Calif., July 20, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today an... Full story

Yahoo Finance • 5 months ago

CeriBell Conference: CFO Highlights 36% Revenue Growth, Expands EEG Platform to Pediatrics and Delirium

CeriBell logo Key Points $89 million revenue in 2025 with 36% YoY growth and 88% gross margins, plus $159 million cash and 31 consecutive quarters of sequential growth — yet only ~3% penetration (647 of ~6,000 U.S. hospitals), signaling... Full story

Yahoo Finance • 5 months ago

CeriBell Highlights 2026 Growth Plan at TD Cowen: 25%-29% Guide, VA Ramp, Delirium Pilot

CeriBell logo Key Points Management reiterated 2026 top-line growth guidance of 25%–29%, citing a larger salesforce (territories up from ~35 to ~55), a footprint in about 11% of U.S. hospitals and roughly 30% in‑account penetration as ca... Full story

Yahoo Finance • 5 months ago

Cautious Guidance Offsets Solid Q4 for CeriBell, Inc. (CBLL), Says Canaccord

CeriBell, Inc. (NASDAQ:CBLL) is among the 12 Most Promising Small-Cap Stocks According to Wall Street Analysts.Cautious Guidance Offsets Solid Q4 for CeriBell, Inc. (CBLL), Says Canaccord CeriBell, Inc. (NASDAQ:CBLL) secures the twelfth p... Full story

Yahoo Finance • 7 months ago

Ceribell to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Ceribell SUNNYVALE, Calif., Dec. 30, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions,... Full story

Yahoo Finance • 8 months ago

Global AI Infrastructure Shift Ignites Biotech Growth Phase

Issued on behalf of Aleen Inc. VANCOUVER, British Columbia, Dec. 09, 2025 (GLOBE NEWSWIRE) -- USA News Group News Commentary – Last month marked a major turning point as Google launched Gemini 3[1], proving that new AI models can now ou... Full story

Yahoo Finance • 8 months ago

Ceribell Receives FDA 510(k) Clearance for Use of ClarityⓇ Algorithm for Neonates

SUNNYVALE, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today an... Full story

Yahoo Finance • 8 months ago

Ceribell to Participate in the Piper Sandler 37th Annual Healthcare Conference

SUNNYVALE, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today an... Full story

Yahoo Finance • 9 months ago

CeriBell raises 2025 revenue guidance to $89M while targeting deeper hospital penetration and expanding pediatric market

Earnings Call Insights: CeriBell, Inc. (CBLL) Q3 2025 MANAGEMENT VIEW * CEO Xingjuan Chao reported continued execution on growth initiatives and described CeriBell as the “category leader in the point-of-care EEG.” Chao highlighted a 3... Full story

Yahoo Finance • 9 months ago

CeriBell GAAP EPS of $0.37, revenue of $22.6M

* CeriBell press release [https://seekingalpha.com/pr/20293154-ceribell-reports-third-quarter-2025-financial-results] (CBLL [https://seekingalpha.com/symbol/CBLL]): Q3 GAAP EPS of $0.37. * Revenue of $22.6M. MORE ON CERIBELL * Seek... Full story

Yahoo Finance • 9 months ago

Ceribell Reports Third Quarter 2025 Financial Results

SUNNYVALE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today re... Full story

Yahoo Finance • 9 months ago

Ceribell to Report Third Quarter 2025 Financial Results on November 4, 2025

SUNNYVALE, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today an... Full story

Yahoo Finance • 10 months ago

Medtech Leader Erica Rogers Joins Ceribell Board of Directors

SUNNYVALE, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell” or the “Company”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological co... Full story

Yahoo Finance • 12 months ago

J.P. Morgan Maintains a Buy Rating on CeriBell (CBLL) With a $21 PT

CeriBell, Inc. (NASDAQ:CBLL) is one of the best medical device stocks to buy according to analysts. J.P. Morgan analyst Robbie Marcus maintained a Buy rating on CeriBell, Inc. (NASDAQ:CBLL) on August 5, setting a price target of $21.00.5 F... Full story

Yahoo Finance • 12 months ago

CeriBell GAAP EPS of -$0.38 beats by $0.02, revenue of $21.2M beats by $0.75M

* CeriBell press release [https://seekingalpha.com/pr/20190071-ceribell-reports-second-quarter-2025-financial-results] (NASDAQ:CBLL [https://seekingalpha.com/symbol/CBLL]): Q2 GAAP EPS of -$0.38 beats by $0.02. * Revenue of $21.2M (+38... Full story

Yahoo Finance • last year

Ceribell to Participate in the Canaccord Genuity 45th Annual Growth Conference

SUNNYVALE, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today an... Full story

Yahoo Finance • last year

CeriBell shares drop 38% following InvestingPro's overvaluation warning

In October 2024, InvestingPro’s Fair Value model identified significant overvaluation in CeriBell, Inc. (NASDAQ:CBLL), a healthcare technology company specializing in seizure diagnostic solutions. The subsequent price movement has strongly... Full story

Yahoo Finance • last year

Ceribell (CBLL) CEO Chao sells $442,500 in stock

Ceribell, Inc. (CBLL) President and CEO Chao Xingjuan, sold 25,000 shares of common stock on July 7, 2025, for a total of $442,500. The shares were sold at prices ranging from $17.02 to $18.7. The transaction comes as the stock, currently... Full story

Yahoo Finance • last year

Ceribell sues Natus Medical for patent infringement

[Judge gavel and law books in court background] CeriBell (NASDAQ:CBLL [https://seekingalpha.com/symbol/CBLL]) said on Monday that it has taken legal action against Natus Medical and its units, claiming that they have infringed on its pate... Full story